Roche Drug Candidate Hits Target in Late-Stage Study for Autoimmune Disease

The company said it would share the study's interim data with health authorities with the aim of bringing the treatment to the market as soon as possible.

本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。